Clinical Trials Browser

INDUSTRY × Advanced Solid Tumors × trebananib × Clear all

NCT00861419 2017-02-08

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors